Location: Burlington, VT
CIK: 0001618205 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Jun 30, 2025
Total Value: $123M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| BMY | BRISTOL-MYERS SQUIBB CO | 685,182 | $38.75M | 31.6% | $56.56 * | $44.70 | +17.6% | COM | 110122108 |
| — | BIODESIX INC | 5,581,176 | $8.539M | 7.0% | $1.53 | $5.70 | — | COM | 09075X108 |
| ACAD | ACADIA PHARMACEUTICALS INC | 338,400 | $6.21M | 5.1% | $18.35 * | $27.98 | -42.3% | COM | 004225108 |
| ELUT | ELUTIA INC | 1,225,489 | $4.583M | 3.7% | $3.74 * | $5.84 | -33.7% | COM | 05479K106 |
| PRTA | PROTHENA CORP PLC | 304,574 | $4.218M | 3.4% | $13.85 * | $30.84 | -48.8% | SHS | G72800108 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 30,240 | $4.128M | 3.4% | $136.50 * | $72.40 | +70.8% | COM | 64125C109 |
| CORT | CORCEPT THERAPEUTICS INC | 74,000 | $3.729M | 3.0% | $50.39 * | $13.51 | +287.7% | COM | 218352102 |
| UTHR | UNITED THERAPEUTICS CORP | 10,000 | $3.528M | 2.9% | $352.84 * | $93.09 | +294.9% | COM | 91307C102 |
| AXGN | AXOGEN INC | 197,000 | $3.247M | 2.6% | $16.48 * | $7.40 | +91.3% | COM | 05463X106 |
| DCGO | DOCGO INC | 764,062 | $3.24M | 2.6% | $4.24 * | $4.50 | -14.4% | COM | 256086109 |
| — | QUIDELORTHO CORP | 67,619 | $3.012M | 2.5% | $44.55 | $67.73 | — | COM | 74838J101 |
| PHR | PHREESIA INC | 114,700 | $2.886M | 2.4% | $25.16 * | $21.44 | -0.4% | COM | 71944F106 |
| TVTX | TRAVERE THERAPEUTICS INC | 148,000 | $2.578M | 2.1% | $17.42 | $13.34 | +32.6% | COM | 89422G107 |
| MASI | MASIMO CORP | 15,280 | $2.526M | 2.1% | $165.30 * | $81.54 | +93.7% | COM | 574795100 |
| HROW | HARROW HEALTH INC | 72,910 | $2.446M | 2.0% | $33.55 * | $6.05 | +632.0% | COM | 415858109 |
| STOK | STOKE THERAPEUTICS INC | 210,000 | $2.316M | 1.9% | $11.03 * | $7.86 | +56.4% | COM | 86150R107 |
| OVV | OVINTIV INC | 52,200 | $2.114M | 1.7% | $40.50 * | $33.44 | +24.5% | COM | 69047Q102 |
| CSTL | CASTLE BIOSCIENCES INC | 78,000 | $2.079M | 1.7% | $26.65 * | $24.73 | +23.2% | COM | 14843C105 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 48,000 | $1.853M | 1.5% | $38.60 * | $33.79 | +29.0% | COM | 74366E102 |
| EQT | EQT CORPORATION | 34,619 | $1.596M | 1.3% | $46.11 * | $33.40 | +21.8% | COM | 26884L109 |
| FHTX | FOGHORN THERAPEUTICS INC | 310,930 | $1.468M | 1.2% | $4.72 * | $16.56 | -56.0% | COM | 344174107 |
| ALKS | ALKERMES PLC | 50,000 | $1.438M | 1.2% | $28.76 | $21.00 | +36.9% | SHS | G01767105 |
| TMCI | TREACE MEDICAL CONCEPTS INC | 161,350 | $1.2M | 1.0% | $7.44 * | $6.58 | +1.7% | COM | 89455T109 |
| NVCR | NOVOCURE LTD | 31,000 | $924K | 0.8% | $29.80 * | $18.86 | +12.2% | ORD SHS | G6674U108 |
| TXG | 10X GENOMICS INC | 50,000 | $718K | 0.6% | $14.36 * | $32.21 | -51.0% | CL A COM | 88025U109 |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 16,000 | $673K | 0.5% | $42.07 * | $49.61 | 0.0% | COM | 90400D108 |
| XNCR | XENCOR INC | 26,000 | $597K | 0.5% | $22.98 | $19.57 | +17.4% | COM | 98401F105 |
| — | KINIKSA PHARMACEUTICALS LTD | 30,000 | $593K | 0.5% | $19.78 | $13.10 | — | COM | G5269C101 |
| KALV | KALVISTA PHARMACEUTICALS INC | 67,000 | $567K | 0.5% | $8.47 * | $15.61 | -33.7% | COM | 483497103 |
| ATEC | ALPHATEC HOLDINGS INC | 58,000 | $532K | 0.4% | $9.18 * | $8.72 | -8.5% | COM | 02081G201 |
| CADL | CANDEL THERAPEUTICS INC | 60,000 | $521K | 0.4% | $8.68 * | $5.91 | 0.0% | COM | 137404109 |
| WVE | WAVE LIFE SCIENCES LTD | 40,000 | $495K | 0.4% | $12.37 * | $5.34 | +149.7% | SHS | Y95308105 |
| INBX | INHIBRX BIOSCIENCES INC | 32,110 | $494K | 0.4% | $15.40 | $14.64 | +4.0% | COM | 45720N103 |
| HALO | HALOZYME THERAPEUTICS INC | 10,000 | $478K | 0.4% | $47.81 * | $51.20 | +0.2% | COM | 40637H109 |
| CYTK | CYTOKINETICS INC | 10,000 | $470K | 0.4% | $47.04 * | $27.06 | +92.0% | COM | 23282W605 |
| APLS | APELLIS PHARMACEUTICALS INC | 14,000 | $447K | 0.4% | $31.91 * | $39.43 | -23.7% | COM | 03753U106 |
| SRPT | SAREPTA THERAPEUTICS INC | 3,500 | $426K | 0.3% | $121.59 | $107.01 | +14.5% | COM | 803607100 |
| — | OUTSET MEDICAL INC | 368,766 | $409K | 0.3% | $1.11 | $1.18 | — | COM | 690145107 |
| XENE | XENON PHARMACEUTICALS INC | 10,000 | $392K | 0.3% | $39.20 * | $30.24 | +36.7% | COM | 98420N105 |
| — | ACCELERATE DIAGNOSTICS INC | 325,239 | $390K | 0.3% | $1.20 | $13.66 | — | COM | 00430H102 |
| TELA | TELA BIO INC | 125,000 | $378K | 0.3% | $3.02 * | $2.81 | 0.0% | COM | 872381108 |
| — | SPRINGWORKS THERAPEUTICS INC | 10,000 | $361K | 0.3% | $36.13 | $36.50 | — | COM | 85205L107 |
| QURE | UNIQURE NV | 20,000 | $353K | 0.3% | $17.66 * | $6.51 | +32.6% | SHS | N90064101 |
| LUNG | PULMONX CORP | 51,000 | $346K | 0.3% | $6.79 * | $6.58 | 0.0% | COM | 745848101 |
| SRRK | SCHOLAR ROCK HOLDING CORP | 8,000 | $346K | 0.3% | $43.22 * | $32.56 | 0.0% | COM | 80706P103 |
| AXSM | AXSOME THERAPEUTICS INC | 4,000 | $338K | 0.3% | $84.61 * | $83.94 | +9.6% | COM | 05464T104 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 40,000 | $301K | 0.2% | $7.52 | $5.77 | +31.6% | COM | 09058V103 |
| ATRA | ATARA BIOTHERAPEUTICS INC | 22,000 | $293K | 0.2% | $13.31 * | $10.54 | 0.0% | COM NEW | 046513206 |
| ARVN | ARVINAS INC | 15,000 | $288K | 0.2% | $19.17 * | $16.46 | +47.6% | COM | 04335A105 |
| — | KARYOPHARM THERAPEUTICS INC | 419,832 | $284K | 0.2% | $0.68 | $7.66 | — | COM | 48576U106 |
| — | BIOHAVEN PHARMACEUTICAL HOLDING CO LTD | 7,365 | $275K | 0.2% | $37.35 | $42.80 | — | COM | G11196105 |
| FOLD | AMICUS THERAPEUTICS INC | 28,000 | $264K | 0.2% | $9.42 * | $14.56 | -28.6% | COM | 03152W109 |
| CGEM | CULLINAN ONCOLOGY INC | 20,000 | $244K | 0.2% | $12.18 * | $40.60 | -64.6% | COM | 230031106 |
| KROS | KEROS THERAPEUTICS INC | 15,000 | $237K | 0.2% | $15.83 * | $49.51 | +5.0% | COM | 492327101 |
| — | BLUEPRINT MEDICINES CORP | 2,700 | $235K | 0.2% | $87.22 | $92.50 | — | COM | 09627Y109 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 4,000 | $217K | 0.2% | $54.15 * | $51.06 | 0.0% | CLASS A ORD | 61559X104 |
| ZBIO | ZENAS BIOPHARMA INC | 16,500 | $135K | 0.1% | $8.19 * | $15.60 | 0.0% | COM | 98937L105 |
| TECL | DIREXION DAILY PHARMACEUTICAL & MEDICAL BULL 3X SH | 18,000 | $128K | 0.1% | $7.10 | $7.10 | — | DLY TECH BULL 3X | 25459W102 |
| GOSS | GOSSAMER BIO INC | 138,176 | $125K | 0.1% | $0.90 | $5.35 | -84.0% | COM | 38341P102 |
| IFRX | INFLARX NV | 50,000 | $124K | 0.1% | $2.47 * | $3.70 | -48.1% | COM | N44821101 |
| LQDA | LIQUIDIA CORPORATION | 10,000 | $118K | 0.1% | $11.76 * | $7.20 | +51.8% | COM | 53635D202 |
| CHRS | COHERUS BIOSCIENCES INC | 82,000 | $113K | 0.1% | $1.38 * | $2.23 | -49.6% | COM | 19249H103 |
| NPCE | NEUROPACE INC | 10,000 | $112K | 0.1% | $11.19 * | $8.69 | 0.0% | COM | 641288105 |
| ALMS | ALUMIS INC | 10,000 | $78,600 | 0.1% | $7.86 * | $12.13 | -17.4% | COM | 022307102 |
| VTYX | VENTYX BIOSCIENCES INC | 28,800 | $63,072 | 0.1% | $2.19 * | $21.31 | -89.4% | COM | 92332V107 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 17,000 | $51,510 | 0.0% | $3.03 * | $13.92 | -76.5% | COM | 98943L107 |
| — | 2SEVENTY BIO INC | 15,833 | $46,549 | 0.0% | $2.94 | $19.43 | — | COM | 901384107 |
| — | CERO THERAPEUTICS HOLDINGS INC | 12,972 | $778 | 0.0% | $0.06 | $3.07 | — | CLASS A COM | 71902K105 |